Diabetes: Removing a limb to save your life
The longer you have diabetes, the higher the risk of developing foot problems, mainly due to neuropathy (damage to the nerves ...
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for the Targeted Treatment of Bullous Pemphigoid (BP)
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...
Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) sBLA Accepted for FDA Priority Review for the Targeted Treatment of Bullous Pemphigoid (BP)
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 Priority Review granted based on positive pivotal results demonstrat ...
UroToday14h
ASCO GU 2025: Treatment Patterns in Prostate Cancer Patients Who Received Darolutamide in the ARAMIS Trial in Spain: PARASEC Study
(UroToday.com) The 2025 GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Javier Puente discussing the PARASEC study assessing treatment patterns in prostate cancer ...
BusinessMirror5h
AFR RESOURCES
SEVERAL amici curiae or “friends of the Court” told the Supreme Court (SC) of a possible violation of the provisions of Constitution in the transfer of Philippine Health Insurance Corporation’s ...
pancan22h
ABOUT Pancreatic Cancer
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.